Introduction {#sec1}
============

Follicular development is a complicated physiological progress, which is essential for a functional ovary and fertility \[[@B1]\]. Follicular development starts with the activation of resting follicles, and gradually leads to the growth and selection of dominant follicles (DFs) from small health follicles \[[@B2],[@B3]\]. It has been demonstrated that disrupted follicular development may result in increased follicular atresia, which is a crucial mechanism of various ovarian pathologies such as endometriosis and polycystic ovary syndrome (PCOS) \[[@B4]\]. Therefore, understanding the molecular mechanism of follicular development is essential for the treatment of ovarian pathologies.

Granulosa cells (GCs) are a group of cells located outside the zona pellucida in an individual follicle \[[@B5]\]. GCs are closely associated with the complex transition from primordial follicles to mature follicles \[[@B6]\]. In recent years, there has been growing interest in the roles of oxidative stress in female reproduction. Accumulating evidence demonstrates that reactive oxygen species (ROS) production is markedly increased in response to diverse stimuli, such as exogenous toxicants and ionizing radiation \[[@B7]\]. ROS are key signals in the initiation of oxidative stress and apoptosis of GCs, leading to dysregulation of follicular development \[[@B8]\]. Thus, attenuating ROS-mediated oxidative stress and apoptosis in GCs may be novel approach for maintaining normal follicular development.

Catalpol is an iridoid glycoside extracted from *Rehmannia* root and has been reported to possess broad activities, especially antioxidative effect \[[@B9],[@B10]\]. Catalpol protects pre-myelinating oligodendrocytes (PreOLs) against ischemia-induced oxidative injury through ERK1/2 signaling pathway \[[@B11]\]. Catalpol protects against hydrogen peroxide (H~2~O~2~)-induced oxidative stress in astrocytes primary cultures via reducing intracellular ROS formation and preventing the decrease in the activities of antioxidant enzymes \[[@B12]\]. Additionally, catalpol may be a candidate agent for the treatment of oxidative stress-induced neurodegenerative disease \[[@B13]\]. However, the direct protective effects of catalpol on follicular development and the underlying molecular mechanisms remain unclear. Thus, the aim of the present study was to evaluate the effect of catalpol on H~2~O~2~-induced oxidative stress and apoptosis in GCs.

Materials and methods {#sec2}
=====================

Cell culture {#sec2-1}
------------

Wistar rats (Beijing Vital Laboratory Animal Technology, Beijing, China) used in the present study were maintained in a room with controlled illumination (lights on: 7--21 h), temperature (26--28°C)and humidity (60 ± 2%) with free access to regular rat diet and water. The animal work took place in Animal Centre of Chengdu University of Traditional Chinese Medicine. The animal experiments were approved by the Animal Care and Use Committee of Hospital of Chengdu University of Traditional Chinese Medicine (Chengdu, China).

GCs were prepared as described previously with some modifications \[[@B14]\]. Briefly, immature female rats (21--27 days old) were injected intraperitoneally with 10 U of pregnant mare serum gonadotropin (PMSG) to stimulate follicular development. Then the rats were anesthetized with sodium pentobarbital (40 mg/kg body weight) and the ovaries were removed. GCs were isolated using a non-enzymatic needle puncture method to release the cells from follicles. The cells were plated and cultured in DMEM (supplemented with 100 U/ml penicillin, 100 U/ml streptomycin and 2 mM [l]{.smallcaps}-glutaminate) containing 10% FBS and incubated at 37°C.

Lactate dehydrogenase release assay {#sec2-2}
-----------------------------------

GCs were seeded in 96-well plates (6000 cells/well) and cultured for 24 h. Then, cells were treated with catalpol at different concentrations ranging from 5 to 40 μM for 24 h. After treatments, lactate dehydrogenase (LDH) activity in culture medium was determined using an LDH cytotoxicity assay kit (Promega, Madison, WI, U.S.A.) according to the protocol.

Cell viability assay {#sec2-3}
--------------------

The CCK-8 assay was performed to assess cell viability of GCs after treatment with 0, 5, 10 and 20 μM of catalpol. After incubation, CCK-8 solution (10 µl; Dojindo, Kumamoto, Japan) was added to each well and incubated for additional 4 h at 37°C. The OD values in each group were recorded using a microplate reader (Bio-Tek, Winooski, VT, U.S.A.) at 450 nm.

Detection of ROS level {#sec2-4}
----------------------

The level of oxidative stress was monitored by the measurement of ROS production using a fluorescent probe H~2~-DCFDA (Sigma--Aldrich, St. Louis, MO, U.S.A.), which can be rapidly oxidized to become highly fluorescent DCF in the presence of ROS. GCs with different treatments were incubated with 4 μM of H~2~-DCFDA at 37°C for 40 min. The cells were observed using an inverted fluorescence microscope and the fluorescence intensities were analyzed by Image-Pro Plus 6.0 software (Media Cybernetics, Bethesda, MD, U.S.A.).

ELISA {#sec2-5}
-----

The levels of antioxidant and apoptotic markers including malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in culture supernatants of GCs were determined with commercial ELISA kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) according to the protocol.

Detection of caspase-3 activity {#sec2-6}
-------------------------------

Caspase 3 activity was detected with Caspase 3 activity assay kit (Beyotime) per the manufacturer's instructions. Briefly, GCs were lysed and incubated with the substrate Ac-DEVD-pNA (2 mM) at 37°C for 1 h. Then the absorbance values were read at 405 nm.

Western blot analysis {#sec2-7}
---------------------

GCs were harvested and resuspended in RIPA lysis buffer (containing 1 mM PMSF). After incubation for 30 min on ice, the mixtures were centrifuged at 14000×***g*** for 10 min. Protein concentration in the supernatants were measured using BCA protein assay. Each sample (containing 30 μg protein) was mixed with 5× loading buffer and boiled at 100°C for 5 min. Proteins were separated by 12% SDS/PAGE and electrophoretically transferred on to polyvinylidene difluoride (PVDF) membranes (Bio-Rad Laboratories, Hercules, CA, U.S.A.). The membranes were blocked with 5% (w/v) non-fat milk in TBST buffer for 2 h to block non-specific protein-binding sites. Subsequently, the membranes were incubated overnight with rabbit monoclonal antibody against bax, bcl-2, caspase-9, PI3K, p-PI3K, Akt, p-Akt, mTOR, p-mTOR or β-actin (Abcam, Cambridge, MA, U.S.A.). After that, the membranes were incubated with horseradish peroxidase (HRP)--conjugated goat anti-rabbit IgG (1:1000; Abcam) in TBST for 1 h at room temperature. After washing for three times, the protein bands were visualized using ECL Western blotting substrate kit (Thermo Fisher Scientific, Waltham, MA, U.S.A.) and quantitated applying a Quantity One image densitometer (Bio-Rad).

Statistical analysis {#sec2-8}
--------------------

All experimental data were expressed as means ± standard deviation (SD) from at least three repeated experiments. Statistical analysis was performed using the SPSS version 13.0 software (SPSS Inc., Chicago, IL, U.S.A.). Statistical significance among multiple groups was determined by one-way Analysis of Variance (ANOVA). Differences were considered significant for *P*\<0.05.

Results {#sec3}
=======

Cytotoxicity effect of catalpol on GCs {#sec3-1}
--------------------------------------

To detect the cytotoxicity effect of catalpol on GCs, GCs were treated with catalpol at different concentrations ranging from 5 to 40 μM for 24 h. LDH cytotoxicity assay showed that catalpol did not exhibit cytotoxicity effect on GCs even in the concentration of 20 μM ([Figure 1](#F1){ref-type="fig"}). Therefore, we selected the concentrations of 5, 10 and 20 μM for the following experiments.

![LDH release assay was used to determine the cytotoxicity effect of catalpol on GCs\
GCs were treated with catalpol at different concentrations ranging from 5 to 40 μM for 24 h. LDH activity in culture medium was determined using an LDH cytotoxicity assay kit. \**P*\<0.05 versus the control GCs.](bsr-40-bsr20194032-g1){#F1}

Catalpol improved cell viability in H~2~O~2~-stimulated GCs {#sec3-2}
-----------------------------------------------------------

Then, we used H~2~O~2~ to stimulate oxidative injury in GCs. GCs were pretreated with 5, 10 and 20 μM of catalpol for 2 h, and then stimulated with H~2~O~2~ for 24 h. As shown in [Figure 2](#F2){ref-type="fig"}, compared with the control group, cell viability in H~2~O~2~ stimulation group was markedly reduced. However, treatment with catalpol (5, 10 and 20 μM) resulted in dose-dependent increase in cell viability.

![Effect of catalpol on cell viability in H~2~O~2~-stimulated GCs\
GCs were pretreated with 5, 10 and 20 μM of catalpol for 2 h, and then stimulated with H~2~O~2~ (150 μM) for 24 h. Cell viability was measured using CCK-8. \**P*\<0.05 versus the control GCs. ^\#^*P*\<0.05 versus the H~2~O~2~-stimulated GCs.](bsr-40-bsr20194032-g2){#F2}

Catalpol inhibited oxidative stress in H~2~O~2~-stimulated GCs {#sec3-3}
--------------------------------------------------------------

The production of ROS and MDA, and the activities of SOD and GSH-Px were evaluated as markers of oxidative stress. As shown in [Figure 3](#F3){ref-type="fig"}A, the intracellular ROS production was markedly increased in GCs exposed to H~2~O~2~ stimulation. While the increased ROS production was attenuated by catalpol in a dose-dependent manner. ELISA proved that H~2~O~2~-caused increase in MDA level and decrease in SOD and GSH-Px activities were mitigated by treatment with catalpol ([Figure 3](#F3){ref-type="fig"}B--D).

![Effect of catalpol on oxidative stress in H~2~O~2~-stimulated GCs\
GCs were pretreated with 5, 10 and 20 μM of catalpol for 2 h, and then stimulated with H~2~O~2~ (150 μM) for 24 h. (**A**) The ROS production was determined using a fluorescent probe. (**B**--**D**) The levels of MDA, SOD and GSH-Px were determined using ELISA. \**P*\<0.05 versus the control GCs. ^\#^*P*\<0.05 versus the H~2~O~2~-stimulated GCs.](bsr-40-bsr20194032-g3){#F3}

Catalpol inhibited cell apoptosis in H~2~O~2~-stimulated GCs {#sec3-4}
------------------------------------------------------------

Then, we examined the effect of catalpol on caspase-3 activity in H~2~O~2~-stimulated GCs. Results from [Figure 4](#F4){ref-type="fig"}A indicated that caspase-3 activity was dramatically increased in H~2~O~2~-stimulated GCs compared with control cells. However, the induction was restored by treatment with catalpol.

![Effect of catalpol on cell apoptosis in H~2~O~2~-stimulated GCs\
GCs were pretreated with 5, 10 and 20 μM of catalpol for 2 h, and then stimulated with H~2~O~2~ (150 μM) for 24 h. (**A**) The caspase-3 activity was determined using ELISA. (**B**) The expression levels of apoptotic markers (bax, bcl-2 and caspase-9) were examined using Western blot analysis. (**C--E**) Quantification analysis of bax, bcl-2 and caspase-9. \**P*\<0.05 versus the control GCs. ^\#^*P*\<0.05 versus the H~2~O~2~-stimulated GCs.](bsr-40-bsr20194032-g4){#F4}

Subsequently, the expression levels of apoptosis-related genes were detected using Western blot analysis. The increased expression levels of bax and caspase-9, as well the decreased expression level of bcl-2 in H~2~O~2~-stimulated GCs were markedly reversed by pretreatment with catalpol ([Figure 4](#F4){ref-type="fig"}B--E).

Catalpol induced the PI3K/Akt/mTOR pathway in H~2~O~2~-stimulated GCs {#sec3-5}
---------------------------------------------------------------------

Following detection of the oxidative injury, the mechanism underlying the function of catalpol was explored. Western blot analysis demonstrated that exposure to H~2~O~2~ led to marked decrease in the expression levels of p-PI3K, p-Akt and p-mTOR. However, catalpol-pretreated GCs appeared significant induction in p-PI3K, p-Akt and p-mTOR expressions ([Figure 5](#F5){ref-type="fig"}).

![Effect of catalpol on the PI3K/Akt/mTOR pathway in H~2~O~2~-stimulated GCs\
GCs were pretreated with 5, 10 and 20 μM of catalpol for 2 h, and then stimulated with H~2~O~2~ for 24 h. (**A**) Western blot analysis was performed to detect the expression levels of PI3K, p-PI3K, Akt, p-Akt, mTOR and p-mTOR. (**B**) Quantification analysis of p-PI3K/PI3K. (**C**) Quantification analysis of p-Akt/Akt. (**D**) Quantification analysis of p-mTOR/mTOR. \**P*\<0.05 versus the control GCs. ^\#^*P*\<0.05 versus the H~2~O~2~-stimulated GCs.](bsr-40-bsr20194032-g5){#F5}

Inhibition of PI3K/Akt reversed the protective effects of catalpol on GCs {#sec3-6}
-------------------------------------------------------------------------

Next, GCs were treated with LY294002 to inhibit the activation of PI3K/Akt/mTOR signaling pathway. The improved cell viability caused by catalpol (20 μM) was prevented by LY294002 ([Figure 6](#F6){ref-type="fig"}A). Additionally, LY294002 treatment elevated ROS production and caspase-3 activity, as compared with catalpol (20 μM)-pretreated GCs ([Figure 6](#F6){ref-type="fig"}B,C). The results indicated that PI3K/Akt/mTOR signaling pathway mediated the protective effects of catalpol on H~2~O~2~-stimulated GCs.

![The protective effects of catalpol on H~2~O~2~-stimulated GCs were reversed by LY294002\
GCs were treated with LY294002 (10 μM) to inhibit the activation of PI3K/Akt signaling pathway. (**A**) Cell viability was measured using CCK-8. (**B**) ROS production was determined using a fluorescent probe. (**C**) Caspase-3 activity was determined using ELISA. \**P*\<0.05 versus the control GCs. ^\#^*P*\<0.05 versus the H~2~O~2~-stimulated GCs. ^&^*P*\<0.05 versus the catalpol + H~2~O~2~ group.](bsr-40-bsr20194032-g6){#F6}

Discussion {#sec4}
==========

GCs play crucial roles in folliculogenesis since they can provide nutrients and maturation-enabling factors to sustain oocytes maturation and protect oocytes from oxidative damage \[[@B6],[@B15]\]. GCs apoptosis is a physiological phenomenon in follicle that can trigger follicular atresia, which are responsible for the reduction in follicle numbers \[[@B16]\]. GCs are sensitive to ROS, which are side products formed during citric acid cycle. ROS including superoxide anion radicals, hydroxyl radicals and H~2~O~2~ are markedly increased in response to stimuli and induce oxidative stress in GCs, leading to GCs dysfunction \[[@B8]\]. Therefore, ROS-induced oxidative damage and apoptosis in GCs are considered as the main etiological factor of ovarian insufficiency \[[@B8]\]. In the current study, we used H~2~O~2~ to induce oxidative damage and apoptosis in GCs.

Increasing literatures have demonstrated that catalpol has the capacity to enhance endogenous antioxidant enzymatic activities and inhibit free radical generation. For instance, catalpol markedly reduces LPS-induced production of pro-inflammatory cytokines and ROS in BV2 microglia through inactivating NF-κB signaling \[[@B17]\]. Catalpol suppresses advanced glycation end-products (AGEs)-induced inflammatory responses through inhibition of ROS in human monocytic THP-1 cells \[[@B18]\]. Catalpol protects PreOLs against ischemia-induced oxidative injury via reducing mitochondrial damage and ameliorating overproduction of ROS \[[@B11]\]. Therefore, we aimed to evaluate the protective effect of catalpol on H~2~O~2~-induced oxidative damage in GCs. We found that catalpol significantly improved cell viability of GCs, reduced ROS and MDA production, and elevated SOD and GSH-Px activities, implying that catalpol attenuated oxidative injury in H~2~O~2~-induced GCs.

It has been reported that ROS-mediated oxidative stress may lead to apoptosis via death receptor pathway or mitochondrial pathway \[[@B19],[@B20]\]. In the mitochondrial pathway, bcl-2 family members are activated or inactivated, thereby results of increase in mitochondrial membrane permeability \[[@B21],[@B22]\]. Thereafter, the caspase signaling is activated, which contributes to the execution of apoptosis \[[@B23]\]. Our results showed that catalpol treatment caused increase in bcl-2 and decrease in bax, as well as caspase-9. These findings suggested that catalpol protected GCs from H~2~O~2~-induced oxidative injury and apoptosis.

PI3K/Akt/mTOR is an important signaling pathway that can block cell apoptosis through regulation of downstream signaling molecules, such as inhibiting the activation of caspase-9, as well inactivating bcl-2 family members \[[@B24]\]. It is well known that the PI3K/Akt signaling pathway plays a crucial role in the regulation of GCs growth apoptosis during follicular development \[[@B25],[@B26]\]. Emerging evidence has proven activation of PI3K/Akt signaling pathway protects GCs from oxidative stress and apoptosis \[[@B27]\]. Interestingly, previous study has reported that catalpol promotes axonal growth via regulating miR-124 to activate PI3K/Akt/mTOR pathway in neurons after ischemia \[[@B30]\]. Catalpol ameliorates AGEs-induced endothelial dysfunction via suppressing the NF-κB/iNOS pathway and activating the PI3K/Akt/eNOS pathway \[[@B31]\]. However, whether catalpol exerted its functions through PI3K/Akt/mTOR signaling pathway remains to be fully elucidated. In the present study, we demonstrated that catalpol caused significant activation of PI3K/Akt/mTOR pathway in GCs in response to H~2~O~2~ stimulation. Furthermore, inhibition of PI3K/Akt/mTOR blocked the protective effects of catalpol on H~2~O~2~-induced oxidative injury and apoptosis in GCs, which suggested that the protective effects of catalpol were mediated by PI3K/Akt/mTOR signaling pathway.

There existed several limitations in the present study. First, we only evaluated the effect of catalpol on rat GCs *in vitro*. An *in vivo* animal study will be considered in the following studies. Second, whether catalpol can be translated in clinical application will require further experiments.

Based on the findings of the present study, we concluded that catalpol has protective effects on H~2~O~2~-induced oxidative injury and apoptosis in GC. These protective effects may be mediated by activation of PI3K/Akt/mTOR signaling pathway. The results indicated that catalpol might be a therapeutic agent for ovarian pathologies through regulation follicular development.
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